Cinclus Pharma (CINPHA) — Cash Flow Reinvestment Rate
Latest as of June 2025:
0.00x
Cinclus Pharma (CINPHA) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting Skr295.00K (capex Skr0.00 plus investments Skr-295.00K) from operating cash flow of Skr63.94 Million. See Cinclus Pharma (CINPHA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr295.00K
Capex + Investments
Operating Cash Flow
Skr63.94 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Cinclus Pharma (None–None)
Year-by-year capital reinvestment analysis for Cinclus Pharma. See CINPHA free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow